FDA Revises Labeling to Limit Pediatric Opioid Use

On Jan. 11, 2018, FDA announced safety labeling changes to prescription opioid cough and cold medicines containing codeine or hydrocodone to limit the use of products in children younger than 18 years old. According to the agency, these changes are being made in response to the risks associatedOriginal Article